Imagoworks Chooses Samsung Securities as Lead Underwriter for Upcoming IPO Targeting KOSDAQ Listing in 2027

Imagoworks Appoints Samsung Securities as Lead Underwriter

Imagoworks Inc., a pioneering company in the field of AI-based digital dentistry, has recently announced that it will collaborate with Samsung Securities as the lead underwriter for its forthcoming initial public offering (IPO) on the KOSDAQ, South Korea's foremost technology-focused stock exchange. This strategic partnership is aligned with Imagoworks' objective of securing a listing by 2027, and the pre-IPO fundraising is slated to commence in the latter half of 2026.

Founded in 2019 as a spin-off from the Korea Institute of Science and Technology (KIST), Imagoworks has positioned itself at the forefront of innovation in dental prosthetics powered by artificial intelligence. Under the leadership of CEO Youngjun Kevin Kim, who boasts over two decades of experience in 3D medical imaging software, the company currently serves dental professionals in more than 110 countries worldwide.

Imagoworks operates two main platforms, namely Dentbird Solutions and AOX. Dentbird Solutions functions as an AI Software as a Service (SaaS) platform that provides a cloud-based solution for the rapid design of dental prosthetics, such as crowns, bridges, and inlays, which can be completed in just one to two minutes without the need for complex software installation for the user. This ease of access allows dental labs and clinics to seamlessly integrate AI-based workflows into their operations without facing significant barriers to entry.

In a move to broaden its reach, Imagoworks signed exclusive distribution agreements with partners across various countries including Japan, Taiwan, and Germany during the International Dental Show (IDS 2025) held in Cologne in March 2025. Furthermore, the company established a U.S. subsidiary named AOX Inc. in Texas, acquiring a local dental laboratory in July 2024 to initiate its AI-driven full-arch prosthetic fabrication service. By merging proprietary AI design technologies with an efficient digital mass-production line, AOX dramatically minimizes both the cost and time involved in full-arch restorations compared to traditional manual workflows.

To date, Imagoworks has successfully raised around $25.8 million in cumulative funding. Notably, its Series C funding round, concluded in December 2024, amassed $15.6 million and included participation from strategic investors, particularly a Taiwan-based private equity firm focused on the dental industry.

Imagoworks plans to pursue its listing on KOSDAQ via a specialized track that prioritizes technological innovation assessments over immediate profitability. The company intends to leverage its proprietary technologies in AI, computer-aided design (CAD), and cloud computing, which have been rigorously validated through extensive commercial deployments across various global markets. The anticipated funds from the IPO will be directed towards expanding Imagoworks' distribution network, enhancing AOX's production and service capabilities in the U.S., and advancing Dentbird's AI capabilities to improve dental prosthetic designs further.

Youngjun Kevin Kim expressed optimism about the company's future, stating, “Imagoworks has been redefining the standard of care in dentistry through AI and cloud technology since its founding. Partnering with Samsung Securities was a strategic decision based on their deep understanding of our global business model and the immense value our technology provides.” The firm looks forward to accomplishing its KOSDAQ listing by 2027, with aspirations to reinforce Imagoworks' position as a global leader in the digital dentistry sphere.

For more details on Imagoworks and its innovative solutions, you can visit their official websites Dentbird and AOX.